Monday, November 14, 2016
- 9:00AM-11:00AM
-
Abstract Number: 1387
Evaluation of Mild to Moderate SLE Flare in Patients with Childhood-Onset Disease
Pediatric Rheumatology – Clinical and Therapeutic Aspects - Poster II: Myositis, Systemic Lupus Erythematosus, Sjögren's Syndrome- 9:00AM-11:00AM
-
Abstract Number: 1379
Evaluation of S100 Proteins As Potential Biomarkers of Global and Renal-Specific Disease Activity in Childhood-Onset Systemic Lupus Erythematosus
Pediatric Rheumatology – Clinical and Therapeutic Aspects - Poster II: Myositis, Systemic Lupus Erythematosus, Sjögren's Syndrome- 9:00AM-11:00AM
-
Abstract Number: 1275
Evaluation of Spine and Tibia Bone Microarchitecture Using Trabecular Bone Score (TBS) and HR-pQCT in Patients with Ankylosing Spondylitis
Imaging of Rheumatic Diseases - Poster II: XR/CT/PET/MRI- 9:00AM-11:00AM
-
Abstract Number: 1226
Evaluation of the Association Between C-Reactive Protein and Anti-Citrullinated Protein Antibody in Rheumatoid Arthritis: Analysis of Two Clinical Practice Data Sets
Health Services Research - Poster II- 9:00AM-11:00AM
-
Abstract Number: 1373
Evaluation of the Reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) and Cutaneous Assessment Tool Binary Method (CAT-BM) in Juvenile Dermatomyositis Among Pediatric Dermatologists, Rheumatologists, and Neurologists
Pediatric Rheumatology – Clinical and Therapeutic Aspects - Poster II: Myositis, Systemic Lupus Erythematosus, Sjögren's Syndrome- 9:00AM-11:00AM
-
Abstract Number: 1366
Evidence Based Criteria for Corticosteroid Tapering/Discontinuation. an Analysis of the Paediatric Rheumatology International Trials Organization (PRINTO) Trial in New Onset Juvenile Dermatomyositis
Pediatric Rheumatology – Clinical and Therapeutic Aspects - Poster II: Myositis, Systemic Lupus Erythematosus, Sjögren's Syndrome- 9:00AM-11:00AM
-
Abstract Number: 1921
Evidence for Prevotella Copri As an Immune-Relevant Bacterium in Rheumatoid Arthritis
T Cell Biology and Targets in Autoimmune Disease - Poster Session I- 9:00AM-11:00AM
-
Abstract Number: 1516
Evidence of Labial Salivary Gland Epithelial Cell Activation from Patients with Rheumatoid Arthritis and Sicca Symptomatology
Rheumatoid Arthritis – Clinical Aspects - Poster II: Co-morbidities and Complications- 9:00AM-11:00AM
-
Abstract Number: 1891
Excellent Reliability of Semiquantitative Nailfold Capillaroscopy Assessment in a Systemic Sclerosis Cohort – a Pilot Study
Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics - Poster II- 9:00AM-11:00AM
-
Abstract Number: 1883
Exercise Habits and Factors Associated with Exercise in Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network (SPIN) Cohort Study
Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics - Poster II- 9:00AM-11:00AM
-
Abstract Number: 1092
Expansion of Age Associated B Cells in Murine Lupus Is Regulated By DEF6 and Its Homologue Swap-70
B Cell Biology and Targets in Autoimmune Disease - Poster I: SLE and Sjögren's- 9:00AM-11:00AM
-
Abstract Number: 1088
Expansion of Transitional B Cells in SLE Patients Correlates with Increased Toll-like Receptor 7 Expression
B Cell Biology and Targets in Autoimmune Disease - Poster I: SLE and Sjögren's- 9:00AM-11:00AM
-
Abstract Number: 1153
Exploring Perceptions of a Rheumatoid Arthritis Specific Smoking Cessation Programme
Education - ARHP Poster- 9:00AM-11:00AM
-
Abstract Number: 1477
Exploring the Inadequate Cardiovascular Disease Prevention in Inflammatory Joint Diseases: Results from a Nationwide Norwegian Project